BackNemaura Medical Overview

Nemaura Medical Gross Profit

Latest gross profit for NMRD: $-4.6M, below the Healthcare sector average of $63B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Gross Profit

N/A

As of Dec 31, 2023

Annual Gross Profit (TTM)

$-4584981.00
3154.88% YoY

Trailing 12 months ending Dec 31, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Nemaura Medical (NMRD) FAQ

Nemaura Medical (NMRD) currently reports a gross profit of $-4.6M as of December 2023. That compares with $150K in the prior-year period — down 3154.9% year over year. That is below the Healthcare sector average of $63B. Use the charts on this page to explore Nemaura Medical's gross profit history and peer comparisons.

Nemaura Medical's gross profit decreased from $150K to $-4.6M — a 3154.9% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nemaura Medical's gross profit of $-4.6M is lower than the Healthcare sector average of $63B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Nemaura Medical reported $-4.6M in gross profit as of December 2023. That compares with $150K in the prior-year period — down 3154.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-4.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $63B. From there, open related valuation or income-statement pages for Nemaura Medical, and consider following NMRD for alerts when major investors trade the stock.